On the track of the deadly parasite Leishmania

May 14, 2014, Youris.com

Leishmaniasis is one of the most underreported and insufficiently monitored diseases in the world. According to the WHO more than 300.000 people are infected annually with the most severe form of this disease - kala-azar. The treatment against this forgotten disease becomes increasingly difficult, and sometimes impossible as the parasites developed resistance against the existing drugs. Now scientists from Europe, India and Nepal have joined forces within the European Research Project Kaladrug-R to regain control against this disease and develop new effective clinical tools.

Leishmaniasis is one of the most underreported and insufficiently monitored diseases in the world affecting mainly the poorest and most disadvantaged people on the Indian Subcontinent, Latin America and East Africa. The disease is caused by tiny , the Leishmania, and transmitted by the bite of an infected sandfly.

Scientists at the Institute of Tropical Medicine in Antwerp, Belgium, are investigating why more and more Leishmania parasites develop resistance against existing drugs. Within the European Research Project Kaladrug-R partners from Europe, India and Nepal are developing simple clinical tools with the aim to use them in the high-risk areas on the Indian Subcontinent. This way, the scientists in India will be able to monitor the effectiveness of the drugs, and the degree of infection, and therefore the spread of drug resistance.

In its most severe form – the visceral Leishmanisis called kala-azar – the parasites seize the internal organs, and without treatment it will lead to death. That is why this form of the disease is stated to be the second largest parasitic killer after malaria. The World Health Organisation (WHO) is reporting 300,000 new cases annually.

As the drug-resistant parasites become more widespread, the treatment against this forgotten disease becomes increasingly difficult, and sometimes impossible. Now, only the protection against the bites of sandflies and new innovative research could help to regain control against this deadly disease.

Explore further: Kala-azar treatment failing in Nepal

Related Stories

Kala-azar treatment failing in Nepal

March 1, 2013
In a recent study, scientists have concluded that the cure rates of Miltefosine, the only oral drug for visceral leishmaniasis available, have significantly decreased. Miltefosine was introduced in the Indian subcontinent ...

Parasite surveillance to support policy against drug resistance

May 14, 2014
Leishmaniasis is a tropical disease known in Europe because it affects dogs. It is caused by the Leishmania parasite carried by sandflies. However, several types of the parasite also affect humans in several regions in the ...

Leishmania parasites with greater infectivity associated with treatment failure

October 8, 2013
Relapses after treatment for Leishmania infection may be due to a greater infectivity of the parasite rather than drug resistance, as has been previously thought, according to a study published in mBio, the online open-access ...

Arsenic in India's water could cause resistance to visceral leishmaniasis treatment

October 29, 2013
(Medical Xpress)—Every year, visceral leishmaniasis infects about 500,000 people and kills about 41,000. Most deaths occur in India's Bihar region, where there is a high level of resistance to the antimony compounds used ...

Belgian scientists develop way to detect superparasites

July 19, 2012
Belgian scientists of the Institute of Tropical Medicine (ITM) in Antwerp, Belgium made a breakthrough in bridging high tech molecular biology research on microbial pathogens and the needs of the poorest of the poor. After ...

Combination therapies are a cost-effective alternative when treating visceral leishmaniasis

September 16, 2013
Visceral leishmaniasis is the second-deadliest parasitic disease after malaria. Each year, thousands fall victim among poor and marginalised populations in low-income countries. Filip Meheus is the first to detail the economic ...

Recommended for you

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.